BridgeBio to stop development of therapy for genetic disorder-June 2024-www.financetom.com

BridgeBio to stop development of therapy for genetic disorder

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BridgeBio to stop development of therapy for genetic disorder

Sep 11, 2024 4:08 AM

Sept 10 (Reuters) - BridgeBio Pharma ( BBIO ) said on

Tuesday it will stop development of its experimental therapy for

a genetic disease that affects the adrenaline-producing gland.

The drugmaker said the results of its early-to-mid stage

study testing the therapy did not meet the threshold to warrant

additional capital investment.

(Reporting by Puyaan Singh; Editing by Shinjini Ganguli)

Previous page： Ascendis Pharma Gets US FDA Approval of Hypoparathyroidism Therapy Next page： JetBlue Launches Senior Notes Offering, Term Loan

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ascendis Pharma Gets US FDA Approval of Hypoparathyroidism Therapy

Aug 12, 2024

07:34 AM EDT, 08/12/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday the US Food and Drug Administration has approved Yorvipath, the company's treatment for hypoparathyroidism, a rare endocrine disease, in adults. The approval is based on data from the global phase 2 and 3 trials. The company said it is finalizing the manufacturing of a commercial product...

JetBlue Launches Senior Notes Offering, Term Loan

Aug 12, 2024

07:42 AM EDT, 08/12/2024 (MT Newswires) -- JetBlue Airways ( JBLU ) said Monday that it plans to offer $400 million of convertible senior notes due 2029. The carrier expects to grant initial purchasers a 13-day option to buy up to an additional $60 million of the notes. Net proceeds are expected to be used to repurchase a portion of...

Top Premarket Gainers

Aug 12, 2024

07:39 AM EDT, 08/12/2024 (MT Newswires) -- PS International ( PSIG ) shares surged 80% pre-bell Monday, extending Friday's rally. Veritone ( VERI ) advanced 18%, rebounding from Friday's slide. Nuburu ( BURU ) shares increased 7.3%, shaving losses from the previous session. Price: 3.6000, Change: +0.19, Percent Change: +5.57 ...

Bitdeer Technologies Group's Q2 Loss Narrows, Revenue Rises

Aug 12, 2024

07:36 AM EDT, 08/12/2024 (MT Newswires) -- Bitdeer Technologies Group ( BTDR ) reported a Q2 loss Monday of $0.14 per diluted share, narrower than its loss of $0.36 a year earlier. Analysts polled by Capital IQ expected earnings of $0.01. Revenue for the quarter ended June 30 was $99.2 million, compared with $93.8 million a year earlier. Analysts surveyed...